SomaLogic expands into China with groundbreaking Biostar Technology Limited Partnership

SomaLogic to deliver 7,000-plex SomaScan® Platform to researchers in attractive Chinese proteomics market

SHANGHAI and BOULDER, Colo., May 10, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics technology, announced today that Biostar Technology Limited will be the company’s first authorized site in China to offer the 7,000-plex SomaScan® Assay and provide SomaScan data to their customers.

“We are delighted to be partnering with SomaLogic to expand the company’s global reach in Asia by providing their next-generation proteomics offering and establishing the first SomaLogic authorized site in Shanghai,” said founding Chief Executive Officer of Biostar and AccuraMed Steven Qiu. “We believe this partnership with SomaLogic will enable customers in China to make use of the SomaScan Assay as a powerful tool to study the mechanisms underlying the physiological and pathological processes in disease areas like cardiovascular and liver diseases, cancer and diabetes.”

Founded in 2006, Biostar Technology Limited is a leading technology supplier in the field of life science and translational medicine in China where the company has more than 1,000 customers in academic research, biopharma, clinical translational and in vitro diagnostics. Biostar will now be the first in the nation to offer SomaLogic’s proteomics technology.

“China is an exciting market for proteomics with tremendous untapped growth potential for SomaLogic,” said SomaLogic Chief Executive Officer Adam Taich. “Researchers in China have long embraced the value of market leading technology and having Biostar Technology Limited as a trusted partner and authorized site for SomaLogic’s SomaScan Platform will now bring the power of our solution to this region.”

Biostar joins Molecular Genomics in Singapore and FonesLife in Japan as SomaLogic authorized sites in the APAC region. Group 42 Healthcare became the first SomaLogic authorized site in the Middle East earlier this year.

About SomaLogic 
SomaLogic is catalyzing drug research and development and biomarker identification as a global leader in proteomics technology. With a single 55 microliter plasma or serum sample, SomaLogic can run 7,000 protein measurements, covering more than a third of the approximately 20,000 proteins in the human body and twice as many as other proteomic platforms. For more than 20 years we’ve supported pharmaceutical companies, and academic and contract research organizations who rely on our protein detection and analysis technologies to fuel drug, disease, and treatment discoveries in such areas as oncology, diabetes, and cardiovascular, liver and metabolic diseases. Find out more at and follow @somalogic on LinkedIn.

Forward Looking Statements Disclaimer
This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements, other than statements of historical fact included in this press release, regarding our strategy, future operations, financial position, estimated revenues, projections, prospects, plans and objectives of management are forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “forecast,” “guidance,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “continue,” “will likely result,” “possible,” “potential,” “predict,” “pursue,” “target” and similar expressions, although not all forward-looking statements contain such identifying words. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements do not guarantee future performance and involve known and unknown risks, uncertainties and other factors.   Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including factors which are beyond SomaLogic’s control. You should carefully consider these risks and uncertainties, including, but not limited to, those factors described under Part I, Item 1A – “Risk Factors” in our Annual Report on Form 10-K and other filings we make with the Securities and Exchange Commission. These filings identify and address important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and SomaLogic assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company will not and does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Media Contact
Emilia Costales

Investor Contacts
Lauren Glaser

GlobeNewswire Distribution ID 8835802

Quantexa Provides ING with Solution to Strengthen and Automate Global Risk Coverage

ING is utilizing Quantexa’s Decision Intelligence Platform to gain a 360-degree view of customer data, identify risk, and continue advancing their world-class customer experiences

LONDON, May 10, 2023 (GLOBE NEWSWIRE) — Today Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors, announced that ING is deploying Quantexa’s platform to strengthen its risk detection and investigative efforts. Being a global bank serving 37 million customers, corporate clients, and financial institutions in 40 countries, ING is determined to protect its customers and fight financial crime.

Using AI and advanced graph analytics capabilities provided by Quantexa’s platform, ING’s investigative teams are focused on developing more effective and efficient global Know Your Customer (KYC) and Anti-Money Laundering (AML) measures. By connecting customers and counterparties, the platform creates context and uncovers complex networks. This further automates the first line defence processes.

ING selected Quantexa’s platform for its ability to aid in the analyzation of internal transaction data and to incorporate external data, to complete a 360-degree view of customer base risk. Early 2023 ING and Quantexa completed a successful first implementation for Trade Finance in Hong Kong and Singapore.

ING and Quantexa are now working on a global rollout with expanded efforts in Financial Markets and Correspondent Banking.

Dan Higgins, Chief Product Officer, Quantexa
“The most effective method to prevent money laundering is by understanding the context underpinning and linking how criminals behave. We are excited to build on our successful track-record of innovation with ING and support them in their mission to improve risk coverage throughout significant global practice areas and their continued effort to be a leader in identifying and combating criminal threats in the banking industry.”

Karim Tadjer, Global KYC lead, ING Group
“At ING, we are committed to the fight against money laundering, economic crime, and continually innovating to ensure the safety and compliance of the bank. We are thrilled to have found a partner with compatible ambitions in Quantexa. By leveraging the contextual insights generated through their platform, we can strengthen our detection models and automate key processes in our KYC and AML measures. This is leading to efficiencies for our investigative teams and improved customer experiences.”

About Quantexa

Quantexa is a global data and analytics software company pioneering Decision Intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, KYC, customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and sixty times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than six hundred employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, New York, Boston, Toronto, Malaga, Brussels, Amsterdam, Luxemburg, Singapore, Melbourne, Sydney, and the UAE. For more information, please visit or follow us on LinkedIn.

Media Enquiries 
C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight

C: Adam Jaffe, SVP of Corporate Marketing
T: +1 609 502 6889
– or –

GlobeNewswire Distribution ID 1000809187

Monaco Energy Boat Challenge: 50+ boats and 23 nations engaged in yachting’s energy transition

Monaco Energy Boat Challenge: 50+ boats and 23 nations engaged in yachting’s energy transition

Monaco Energy Boat Challenge, the largest meeting for alternative energy sources organised by Yacht Club de Monaco from July 3rd to July 8th.

MONACO, May 10, 2023 (GLOBE NEWSWIRE) — Peru, US, Canada, India but also Turkey, Croatia, Italy and Portugal. These are some of the countries taking part in the Monaco Energy Boat Challenge, the largest meeting for alternative energy sources organised by Yacht Club de Monaco from July 3rd to July 8th. Already 27 teams from 23 nations have completed their registrations in the Solar and Energy classes, categories composed mainly of engineering students. The event has also attracted around 15 professional entrants coming to present their latest innovations at the first YCM E-Boat Rally from Monaco to Cala del Forte in Italy. YCM has also set itself a zero-emission goal with its 100% electric press and safety boats. A total of 50-plus boats will be out on the sea in the bay of Monaco. “YCM aims to be a driving force in the environmental transition, an ambition that is part of the collective ‘Monaco, Capital of Advanced Yachting’ approach”, said YCM General Secretary Bernard d’Alessandri. Focused on R&D in open source, with a full programme of nautical challenges on the sea, daily Tech Talks, industry pitches and a conference, this unique in the world event is supported by the Prince Albert II of Monaco Foundation. Other partners include Credit Suisse, BMW and SBM Offshore, with key yachting industry players involved such as the Sanlorenzo, Oceanco, Ferretti and Monaco Marine shipyards.

As every year, sustainability discussions will be held at the event with a half-day conference (Thursday 6th July) entitled ‘Challenges, Engagement and Adoption to take stock of the challenges ahead and progress made’. Next day (Friday 7th July) it will be time for the 4th Hydrogen Round Table organised by the Prince Albert II of Monaco Foundation, the Energy Transition Mission and the YCM. Monegasque, French and international governmental and institutional stakeholders will come together with international developers of hydrogen projects. Every year the number of hydrogen-related prototypes entering this Challenge increases, up from two in 2019 to six in 2021, seven in 2022 and this year nine teams have taken up the hydrogen challenge. The program complements the well-established Job Forum which connects industry professionals with talented future marine engineers, an initiative which positions yachting as a job generator.

For more information:
Press Office LaPresse

A photo accompanying this announcement is available at

The photo is also available at Newscom,, and via AP PhotoExpress.

GlobeNewswire Distribution ID 8835972

Vista to simplify the approach to trading aircraft globally


Vista Global Trading

Chief Business Officer Bill Papariella to lead the expansion of Vista’s trading services

Dubai, May 10, 2023: Vista Global Holding (Vista), the world’s leading private aviation group, has today announced that it will be centralizing and expanding its aircraft trading service offerings with a dedicated focus on worldwide trading of business aircraft across corporates, private owners and the brokerage market. Vista Global Trading will transform the buying and selling of assets within business aviation, through:

  • Allowing aircraft owners globally to move to Vista’s asset free Program membership by easily and quickly divesting their current asset to Vista Global Trading;
  • Accelerating lead times in a highly fragmented market, through a global infrastructure of experts and rapid decision making;
  • Providing support to existing aircraft owners, operators and brokers by integrating institutional expert knowledge through comprehensive technology and analytical market support.

Vista Global Trading will be led by Bill Papariella, Chief Business Officer at Vista — which he joined in 2022 following its acquisition of Jet Edge. Bill is also a member of the Vista group’s Executive Committee.

Announcing the creation of Vista Global Trading, Thomas Flohr, Vista’s Founder and Chairman said: The launch of Vista Global Trading confirms Vista’s position as the driver of innovation and change, and is the start of an exciting new chapter for the global business aviation industry. We are transforming the trading marketplace worldwide to enable valuable transactions to occur when speed and market appropriateness is critical, whilst giving access to asset free flying solutions globally through Vista’s subscription memberships. Following Vista’s acquisition of Jet Edge last year, Bill’s outstanding leadership and expertise have been critical in the expansion of our service offerings and I am delighted that he will be playing a central role in driving the success of Vista Global Trading.”

Bill Papariella, Chief Business Officer at Vista and Vista Global Trading said: I am thrilled to announce this new service. It leverages the huge power of being part of the Vista universe and capitalizes on a key opportunity across the increasingly diversified requirements of the business aviation world. Vista Global Trading will benefit aircraft owners, large corporations, Vista Members, global fleet operators and the brokerage community by providing them with further opportunity to trade their assets. It will help maximize the efficiency of their assets during their lifecycle, and enjoy seamless and quick access to Vista’s asset free subscription Program, securing guaranteed availability on a global fleet of over 360 aircraft, by trading in their asset to us. Our unique team of global experts specialize in the current valuations of all aircraft types and have deep expertise in assessing the ever-changing industry market and financing dynamics.”

Vista Global Trading will utilize Vista’s existing aircraft management offering and its full-service aircraft brokerage. Vista Aircraft Management, the Group’s private aviation management company for owners with ultra-long range, large cabin and super-midsize aircraft will become an ancillary charter management arm of Vista Global Trading. Jet Edge Partners, will continue to operate as a separate U.S. aircraft sales and listing company led by Kevin White, and will have a close partnership with Vista Global Trading, as its subsidiary aircraft brokerage.

– Ends –

About Vista
Vista Global Holding’s (Vista) subsidiaries provide worldwide business flight services. A global group headquartered at the DIFC in Dubai, Vista integrates a unique portfolio of companies offering asset-free services to cover all key aspects of business aviation: guaranteed and on demand global flight coverage; subscription and Membership solutions; trading and management services; and cutting-edge mobility technology. The Group’s mission is to lead the change to provide clients with the most advanced flying services at the very best value, anytime, anywhere around the world. Vista’s knowledge and understanding of all facets of the industry deliver the best end-to-end offering and technology to all business aviation clients, through its VistaJet and XO branded services and duly licensed carriers. Vista is not a direct air carrier and does not operate or charter flights.
More Vista information and news at


Vista Global Holding Limited (“Vista”) does not own or operate any aircraft. All flights are performed by FAA-licensed/DOT-registered EASA or U.S. certified Vista group direct air carriers and/or partner operators. Vista holds non-controlling minority stakes in XOJET Aviation, GMJ Air Shuttle, JetSelect, Wester Air Charter, Red Wing Aviation and Talon Air


GlobeNewswire Distribution ID 1000809032

Mercurius Health equips Robert Janker Klinik with integrated oncology solutions from Philips and Elekta

May 10, 2023

The hospital will be equipped with state-of-the-art diagnostic and therapeutic oncology solutions over the next three years, contributing to enhanced patient care

Amsterdam, the Netherlands, Stockholm, Sweden, and Madrid, Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, radiation therapy leader Elekta (EKTA-B.ST), and oncology service provider Mercurius Health today announced the signing of a 3-year agreement under which Philips and Elekta will install state-of-the-art diagnostic and therapeutic oncology equipment and associated informatics solutions at Mercurius Health’s newly-acquired Robert Janker Klinik cancer center in Bonn, Germany. The investment in Philips and Elekta solutions by Mercurius Health is part of its commitment to establishing a major presence in Germany, following the company’s acquisition of Robert Janker Klinik earlier this year.

The agreement has been enabled by the strategic partnership between Philips and Elekta to advance comprehensive personalized cancer care through the deployment of precision oncology solutions. The Robert Janker Klinik, a specialized hospital in oncology and palliative care, focuses on minimally invasive diagnostics and treatments for cancer. The hospital has three inpatient departments (radiology, radiotherapy and palliative care) and an outpatient unit for radiotherapy. It employs around 130 staff and treats patients from across the region as well as national and international patients.

“This major investment in cutting-edge technology by Mercurius Health means many of the projects currently in planning can be rapidly moved forward, making us a showcase for what the future of cancer care will look like,” said Prof. Dr. Attila Kovács, Head Physician of the Clinic for Diagnostic and Interventional Radiology and Neuroradiology.

“The combination of Philips’ diagnostic imaging and oncology informatics solutions, and Elekta’s radiation therapy solutions means we will be able to offer our patients state-of-the-art therapy for tumors such as prostate and liver cancer that are currently difficult to treat, improving clinical outcomes,” said Prof. Dr. Michael Pinkawa, Radiation Oncologist and Head of Radiotherapy at Robert Janker Klinik.

Bringing data and actionable insights to the benefit of cancer patients
To make a precise and informed diagnosis and select the optimal therapy for each individual cancer patient, oncologists often need to consider and scrutinize around 10,000 data points, many of which reside in disparate IT systems – electronic medical records, lab systems, radiology, pathology, and genomics. Philips and Elekta bring all this data together and translate it into actionable insights, and pathways with predictable outcomes for each patient [1].

The combined solutions enable oncologists to deliver precise and personalized therapies that treat tumors effectively while sparing adjacent tissue and organs at risk. Installed in Robert Janker Klinik, they will provide Mercurius Health with a platform to showcase its consultancy and B2B oncology services in the German market and continue its pioneering work in increasing productivity, improving patient and staff experience, and enhancing clinical care.

[1] Results from case studies are not predictive of results in other cases. Results in other cases may vary.

For further information, please contact:

Mark Groves
Philips Global Press Office
Tel: +31 631 639 916

Mattias Thorsson
Vice President, Head of Corporate Communications, Elekta
Tel: +46 70 865 8012

Laura Terzagui Fernández
Director of Marketing & Communications, Mercurius Health
Tel: +34 650 446 543

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it’s personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit or follow @Elekta on Twitter.

About Mercurius Health
Mercurius Health is the European leader of B2B services to hospitals and oncology centers with specializations in radiotherapy, nuclear medicine and radiology. Services include advisory, remote planning, commissioning, training & education, outsourced operations and financing of equipment used in centers and are mostly provided in Europe and Africa.


GlobeNewswire Distribution ID 1000809152

VCI Global Limited Signs IPO Advisory Mandate With Agroz Group

KUALA LUMPUR, Malaysia, May 10, 2023 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) announced that it has signed an Initial Public Offering (“IPO”) advisory mandate with Agroz Group Sdn Bhd (“Agroz”). This IPO advisory mandate entails a USD2 million advisory fees and also a success fees of 5% of the market capitalisation of Agroz when listed.

The scope of work under this mandate includes, but is not limited to:

  • review and assist with the reorganization with respect to the capital structure of Agroz;
  • perform preliminary due diligence on the business and develop equity story for Agroz;
  • review on operating and financial performance, governance and management structure of Agroz;
  • interview the professionals required and make such recommendations for Agroz’s engagement;
  • arrange for the formation of the due diligence working group (“DDWG”);
  • management of the DDWG in producing professional materials in a timely manner;
  • review, comment and assist in responding to U.S. Securities and Exchange Commission (“SEC”) and Nasdaq with regards to any queries that may arise; and
  • assist in obtaining all requisite regulatory approvals.

“With this latest IPO advisory mandate win, this further exemplifies clients’ trust in our capabilities in the provision of such financial related advisory services. With the global economies sailing further away from the pandemic era, I am confident more companies will seek to be listed and we will be at hand to bid for more of such contracts,” said Dato’ Victor Hoo, Chairman and Group Director of VCI Global.

Agroz, founded by Gerard Lim in late 2020, is an agriculture technology company. The company utilises Controlled Environment Agriculture (“CEA”) in the provision of solutions in sustainable farming, to improve food safety, food security and sustainability, delivering value direct to the community. Gerard Lim has established a proven track record in leading, managing and building businesses from start-up stage, to turnaround management, and growing businesses into multi-million-dollar ventures.

“Agroz is experiencing high growth and demand for our Controlled Environment Agriculture AgTech solutions and services are strong as we expand into Southeast Asia. To support this growth, we are seeking to raise capital through an IPO. We have selected VCI Global as our IPO advisor due to their outstanding track record as well as understanding of our industry sector,” said Gerard Lim, Chief Executive Officer of Agroz.

About VCI Global Limited

VCI Global is a multi-disciplinary consulting group with key advisory practices in the areas of business and technology. The Company provides business and boardroom strategy services, investor relation services, and technology consultancy services. Its clients range from small-medium enterprises and government-linked agencies to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from Malaysia, but also serves some clients from China, Singapore, and the US.

For more information on the Company, please log on to

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company’s ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of Coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company’s products and the Company’s customers’ economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company’s filings with the United States Securities and Exchange Commission. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.


Issued by Imej Jiwa Communications Sdn Bhd on behalf of VCI Global Limited
For media queries, please contact:

Imej Jiwa Communications Sdn Bhd
Chris Chuah

GlobeNewswire Distribution ID 8835906